Search Results 521-530 of 17011 for citrulline loading phase

  1. Infant development: Birth to 3 months - Mayo Clinic

    Most babies reach certain milestones at similar ages, but infants take their own path as they develop. Expect your baby to grow and develop at your baby's own ...

  2. Clinical trials - Gastroenterology and Hepatology

    Because it is a silent disease (without symptoms until end stage) and the lab tests can be normal, it can be missed in early stages. The fat in the liver can ...

  3. Clinical trials - Oncology (Medical)

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

  4. Study Of Datopotamab Deruxtecan Plus Carboplatin Or Cisplatin Versus Gemcitabine Plus Carboplatin Or Cisplatin In Participants With Locally Advanced Or Metastatic Urothelial Carcinoma - Mayo Clinic

    About this study. This is a global, multicenter, randomized, open-label, Phase 2/3 study of Dato-DXd plus carboplatin or cisplatin versus gemcitabine plus ...

  5. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma ...

  6. Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study to Compare the Effectiveness of an Invasive Treatment Approach versus Conservative Medication Alone Strategy for Patients with Stable Ischemic Heart Disease - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

    This randomized phase I/II trial studies the side effects and the best dose of temsirolimus when given together with bortezomib, rituximab, and dexamethasone ...

  9. Clinical trials - Oncology (Medical)

    ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety ... Correlate this measurement with mean lobar absorbed radiation dose and embolic load ... load. The Patient Group ...

  10. A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) (KarMMa-4) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...